Klein M, Musacchio J M
Department of Pharmacology, New York University Medical Center, NY 10016.
J Pharmacol Exp Ther. 1989 Oct;251(1):207-15.
Dextromethorphan (DM), a non-narcotic antitussive, binds in the guinea pig brain to specific high- and low-affinity sites with Kd values of 57 nM and 24 microM, respectively (Musacchio et al., 1988). The antitussives carbetapentane, caramiphen, butamirate and dimethoxanate competed with the high-affinity binding of [3H]DM at pH 7.4 with nanomolar Ki values. Sigma site ligands showed high affinity for [3H]DM binding sites. The rank order of potency was: haloperidol greater than (+)-pentazocine greater than (+)-cyclazocine greater than 3-(-3-hydroxyphenyl)-N-(1-propyl)piperidine greater than (+)-N-allylnormetazocine greater than (-)-butaclamol much greater than (+)-butaclamol (-)-N-allylnormetazocine. The antipsychotic perphenazine competed with low nanomolar Ki values, whereas rimcazole was weaker. The antidepressant opipramol and the benzomorphan (+)2'methoxyphenazocine were the most effective drugs tested, with Ki values of 0.4 nM. By contrast, MK-801 and phencyclidine hydrochloride were very weak competitors for [3H]DM binding. The diphenylalkylamines were the most effective competitors of the calcium channel blocking agents: prenylamine and cinnarizine had Ki values of 17 and 22 nM, respectively. Lidoflazine and hydroxyzine were slightly less potent, but nifedipine and the benzothiazepine diltiazem were much weaker. Potassium channel blockers inhibited DM binding in pharmacologically relevant concentrations: primaquine was the most effective with a Ki of 0.5 microM. Other antimalarial potassium channel blockers tested inhibited binding in the micromolar range. 4-Aminopyridine and tetraethylammonium had Ki values of 0.76 and 1.40 mM, respectively.(ABSTRACT TRUNCATED AT 250 WORDS)
右美沙芬(DM)是一种非麻醉性镇咳药,在豚鼠脑中与特定的高亲和力和低亲和力位点结合,其解离常数(Kd)值分别为57 nM和24 μM(穆萨基奥等人,1988年)。镇咳药卡比喷托、卡拉美芬、布他米酯和地美索酯在pH 7.4时与[3H]DM的高亲和力结合竞争,其抑制常数(Ki)值为纳摩尔级别。西格玛位点配体对[3H]DM结合位点显示出高亲和力。效力顺序为:氟哌啶醇大于(+)-喷他佐辛大于(+)-环唑辛大于3-(-3-羟基苯基)-N-(1-丙基)哌啶大于(+)-N-烯丙基去甲左啡诺大于(-)-布他拉莫大于(+)-布他拉莫(-)-N-烯丙基去甲左啡诺。抗精神病药奋乃静以低纳摩尔的Ki值竞争,而利姆卡唑较弱。抗抑郁药奥匹哌醇和苯吗喃(+)2'-甲氧基苯唑辛是测试中最有效的药物,Ki值为0.4 nM。相比之下,MK-801和盐酸苯环己哌啶是[3H]DM结合的非常弱的竞争者。二苯烷基胺是钙通道阻滞剂中最有效的竞争者:普尼拉明和桂利嗪的Ki值分别为17和22 nM。利多氟嗪和羟嗪的效力稍低,但硝苯地平和苯并硫氮䓬地尔硫䓬则弱得多。钾通道阻滞剂在药理学相关浓度下抑制DM结合:伯氨喹最有效,Ki为0.5 μM。测试的其他抗疟钾通道阻滞剂在微摩尔范围内抑制结合。4-氨基吡啶和四乙铵的Ki值分别为0.76和1.40 mM。(摘要截短于250字)